|
November 16, 2020
|
Histogen Announces Closing of $4.5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
|
|
|
November 12, 2020
|
Histogen Announces $4.5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
|
|
|
November 10, 2020
|
Histogen Reports Third Quarter 2020 Earnings and Provides Business Update
|
|
|
October 28, 2020
|
Histogen to Report Third Quarter 2020 Earnings on November 12, 2020
|
|
|
October 27, 2020
|
Histogen and Amerimmune Enter into a Collaborative Development and Commercialization Agreement for Emricasan in the Treatment of COVID-19
|
|
|
October 19, 2020
|
Histogen Appoints Moya Daniels as Executive Vice President and Head of Regulatory, Quality and Clinical Operations
|
|
|
October 5, 2020
|
Histogen Announces Completion of Final Dosing Timepoint Milestone in its 1b/2a Trial for Androgenic Alopecia in Men
|
|
|
September 29, 2020
|
Histogen Announces Update for its HST-002 Dermal Filler Program
|
|
|
September 16, 2020
|
Histogen Announces $2M Grant Award from the Department of Defense for Clinical Advancement of HST-003 for Cartilage Regeneration in the Knee
|
|
|
September 10, 2020
|
Histogen Announces Completion of Dosing Milestone in its 1b/2a Trial for Androgenic Alopecia in Men
|
|
